Stem cells from bone marrow do well in Mayo heart failure trial

04/17/2013 | Daily Express (London)

Heart function improved for all patients who received autologous, bone marrow-derived stem cells in a trial conducted by the Mayo Clinic's Center for Regenerative Medicine in Minnesota, according to a study in the Journal of the American College of Cardiology. The stem cells were modified to act as cardiac cells before being injected into the patients, who were being treated for heart failure.

View Full Article in:

Daily Express (London)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Corporate Counsel - Healthcare Law Group
Genentech
South San Francisco, CA
Manager/Senior Manager, Health Services Analytics
Avalere Health
Washington, DC